Novel RasGRF1-derived Tat-fused peptides inhibiting Ras-dependent proliferation and migration in mouse and human cancer cells
- 1 January 2012
- journal article
- Published by Elsevier in Biotechnology Advances
- Vol. 30 (1) , 233-243
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Targeting Mutated K-ras in Pancreatic Adenocarcinoma Using an Adjuvant VaccineAmerican Journal of Clinical Oncology, 2011
- The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disordersHuman Mutation, 2008
- K-ras as a Target for Lung Cancer TherapyJournal of Thoracic Oncology, 2008
- Glucose‐Derived Ras Pathway Inhibitors: Evidence of Ras–Ligand Binding and Ras–GEF (Cdc25) Interaction InhibitionChemBioChem, 2007
- GEFs and GAPs: Critical Elements in the Control of Small G ProteinsCell, 2007
- Stable suppression of tumorigenicity by virus-mediated RNA interferenceCancer Cell, 2002
- Blocking Oncogenic Ras Signaling for Cancer TherapyJNCI: Journal of the National Cancer Institute, 2001
- A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblastsOncogene, 2000
- Guanosine triphosphatase stimulation of oncogenic Ras mutantsProceedings of the National Academy of Sciences, 1999
- The structural basis of the activation of Ras by SosNature, 1998